186 related articles for article (PubMed ID: 25083769)
1. Identification of ALK gene alterations in urothelial carcinoma.
Bellmunt J; Selvarajah S; Rodig S; Salido M; de Muga S; Costa I; Bellosillo B; Werner L; Mullane S; Fay AP; O'Brien R; Barretina J; Minoche AE; Signoretti S; Montagut C; Himmelbauer H; Berman DM; Kantoff P; Choueiri TK; Rosenberg JE
PLoS One; 2014; 9(8):e103325. PubMed ID: 25083769
[TBL] [Abstract][Full Text] [Related]
2. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening.
Lee J; Kim HC; Hong JY; Wang K; Kim SY; Jang J; Kim ST; Park JO; Lim HY; Kang WK; Park YS; Lee J; Lee WY; Park YA; Huh JW; Yun SH; Do IG; Kim SH; Balasubramanian S; Stephens PJ; Ross JS; Li GG; Hornby Z; Ali SM; Miller VA; Kim KM; Ou SH
Oncotarget; 2015 Sep; 6(27):24320-32. PubMed ID: 26172300
[TBL] [Abstract][Full Text] [Related]
3. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
4. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic lymphoma kinase (ALK) gene alteration in gastric signet ring cell carcinoma.
Zhao R; Jiang W; Li X; Zhang W; Song L; Chang Z; Cao W; Cao X; Zong H
Cancer Biomark; 2016 Mar; 16(4):569-74. PubMed ID: 27002760
[TBL] [Abstract][Full Text] [Related]
6. Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor.
Won JK; Keam B; Koh J; Cho HJ; Jeon YK; Kim TM; Lee SH; Lee DS; Kim DW; Chung DH
Ann Oncol; 2015 Feb; 26(2):348-54. PubMed ID: 25403583
[TBL] [Abstract][Full Text] [Related]
7. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
[TBL] [Abstract][Full Text] [Related]
8. [Anaplastic large cell lymphoma: an array-based comparative genomic hybridization study].
Wang M; Liu R; Su LY; Yu R; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):580-3. PubMed ID: 24314241
[TBL] [Abstract][Full Text] [Related]
9. Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Lin C; Shi X; Yang S; Zhao J; He Q; Jin Y; Yu X
Lung Cancer; 2019 May; 131():62-68. PubMed ID: 31027700
[TBL] [Abstract][Full Text] [Related]
10. ALK gene amplification is associated with poor prognosis in colorectal carcinoma.
Bavi P; Jehan Z; Bu R; Prabhakaran S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Al-Halouly T; Sairafi R; Uddin S; Al-Kuraya KS
Br J Cancer; 2013 Nov; 109(10):2735-43. PubMed ID: 24129244
[TBL] [Abstract][Full Text] [Related]
11. Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing.
Jurmeister P; Lenze D; Berg E; Mende S; Schäper F; Kellner U; Herbst H; Sers C; Budczies J; Dietel M; Hummel M; von Laffert M
Lung Cancer; 2015 Feb; 87(2):122-9. PubMed ID: 25534130
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization shows complex genomic changes of plasmacytoid urothelial carcinoma.
Keck B; Ellmann C; Stoehr R; Weigelt K; Goebell PJ; Kunath F; Taubert H; Hartmann A; Wullich B; Wach S
Urol Oncol; 2014 Nov; 32(8):1234-9. PubMed ID: 25087089
[TBL] [Abstract][Full Text] [Related]
13. Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non-small-cell Lung Cancer: Implications of FISH-positive Patterns.
Clavé S; Rodon N; Pijuan L; Díaz O; Lorenzo M; Rocha P; Taus Á; Blanco R; Bosch-Barrera J; Reguart N; de la Torre N; Oliveras G; Espinet B; Bellosillo B; Puig X; Arriola E; Salido M
Clin Lung Cancer; 2019 Jul; 20(4):e421-e429. PubMed ID: 30898567
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
[TBL] [Abstract][Full Text] [Related]
15. A study of ALK-positive pulmonary squamous-cell carcinoma: From diagnostic methodologies to clinical efficacy.
Wang H; Sun L; Sang Y; Yang X; Tian G; Wang Z; Fang J; Sun W; Zhou L; Jia L; Tsao MS; Shi H; Lin D
Lung Cancer; 2019 Apr; 130():135-142. PubMed ID: 30885334
[TBL] [Abstract][Full Text] [Related]
16. ALK alterations in salivary gland carcinomas.
Majewska H; Gorczyński A; Czapiewski P; Menon R; Mueller J; Lakis S; Heuckmann JM; Laco J; Gupta R; Andreasen S; Stodulski D; Iliszko M; Dziadziuszko R; Jassem J; Heukamp LC; Biernat W
Virchows Arch; 2021 May; 478(5):933-941. PubMed ID: 33237469
[TBL] [Abstract][Full Text] [Related]
17. ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations.
Peretti U; Ferrara R; Pilotto S; Kinspergher S; Caccese M; Santo A; Brunelli M; Caliò A; Carbognin L; Sperduti I; Garassino M; Chilosi M; Scarpa A; Tortora G; Bria E
Respir Res; 2016 Aug; 17(1):105. PubMed ID: 27561692
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization.
Ali SM; Hensing T; Schrock AB; Allen J; Sanford E; Gowen K; Kulkarni A; He J; Suh JH; Lipson D; Elvin JA; Yelensky R; Chalmers Z; Chmielecki J; Peled N; Klempner SJ; Firozvi K; Frampton GM; Molina JR; Menon S; Brahmer JR; MacMahon H; Nowak J; Ou SH; Zauderer M; Ladanyi M; Zakowski M; Fischbach N; Ross JS; Stephens PJ; Miller VA; Wakelee H; Ganesan S; Salgia R
Oncologist; 2016 Jun; 21(6):762-70. PubMed ID: 27245569
[TBL] [Abstract][Full Text] [Related]
19. ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm.
Marchetti A; Di Lorito A; Pace MV; Iezzi M; Felicioni L; D'Antuono T; Filice G; Guetti L; Mucilli F; Buttitta F
J Thorac Oncol; 2016 Apr; 11(4):487-95. PubMed ID: 26916631
[TBL] [Abstract][Full Text] [Related]
20. Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapy.
Camidge DR; Skokan M; Kiatsimkul P; Helfrich B; Lu X; Barón AE; Schulte N; Maxson D; Aisner DL; Franklin WA; Doebele RC; Varella-Garcia M
Cancer; 2013 Nov; 119(22):3968-75. PubMed ID: 24022839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
